These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Central effects of H1 and H2 antihistamines. Nicholson AN Aviat Space Environ Med; 1985 Apr; 56(4):293-8. PubMed ID: 2859849 [TBL] [Abstract][Full Text] [Related]
6. H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs. Lorenz W; Doenicke A; Schöning B; Mamorski J; Weber D; Hinterlang E; Schwarz B; Neugebauer E Agents Actions; 1980 Apr; 10(1 Pt 2):114-24. PubMed ID: 6155762 [TBL] [Abstract][Full Text] [Related]
7. Comment: effects and side effects of H1- and H2-receptor antagonists in clinical situations. Sewing KF Klin Wochenschr; 1982 Sep; 60(17):1046-7. PubMed ID: 6127436 [TBL] [Abstract][Full Text] [Related]
8. H1- and H2-receptor antagonists prevent histamine release in allergic patients after the administration of midazolam-ketamine. A randomized controlled study. Kimura K; Adachi M; Kubo K Inflamm Res; 1999 Mar; 48(3):128-32. PubMed ID: 10219654 [TBL] [Abstract][Full Text] [Related]
11. Perioperative uses of histamine antagonists. Lorenz W; Ennis M; Doenicke A; Dick W J Clin Anesth; 1990; 2(5):345-60. PubMed ID: 1702978 [TBL] [Abstract][Full Text] [Related]
12. [Treatment with antihistaminic preparations]. Bozhkov B Vutr Boles; 1990; 29(3):1-8. PubMed ID: 1704665 [No Abstract] [Full Text] [Related]
13. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Sansom JE; Brooks J; Burton JL; Archer CB Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766 [TBL] [Abstract][Full Text] [Related]
14. [Total review of all results collected worldwide with astemizole (Hismanal)]. Rombaut N; Vanden Bussche G Z Hautkr; 1985; 60 Suppl 1():29-42. PubMed ID: 2859711 [TBL] [Abstract][Full Text] [Related]
15. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Richards DM; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1984 Jul; 28(1):38-61. PubMed ID: 6204835 [TBL] [Abstract][Full Text] [Related]
16. Newer non-sedating antihistamines. Will they replace older agents? Brandon ML Drugs; 1985 Nov; 30(5):377-81. PubMed ID: 2866084 [No Abstract] [Full Text] [Related]
17. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [TBL] [Abstract][Full Text] [Related]
19. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects. Kaliner MA Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437 [TBL] [Abstract][Full Text] [Related]
20. Practical therapeutics: the use of histamine receptor antagonists in contemporary times. Obel AO East Afr Med J; 1984 Jul; 61(7):578-82. PubMed ID: 6152737 [No Abstract] [Full Text] [Related] [Next] [New Search]